Radiopharmaceuticals poised for major growth as demand surges in cancer and cardiac care

The global radiopharmaceutical market is undergoing a period of robust expansion, driven by the increasing burden of chronic illnesses such as cancer and heart disease. In 2024, the market stood at an estimated US$6.8 billion and is expected to grow ...